You have no items in your shopping cart.
Active
Description
Research Area
Cardiovascular Research
Images & Validation
−
Item 1 of 4
| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Target | VEGF165 |
| Reactivity | Human |
| Tag | Native |
| Expression Region | Ala 27 - Arg 191 |
| Endotoxins | 0.01 EU per μg |
| Conjugation | Unconjugated |
| MW | 19.2 kDa |
| Purity | >95% as determined by SDS-PAGE; >95% as determined by SEC-MALS. |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | PBS, pH 7.4 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−RP1-261G23.1, MGC70609, MVCD1, VEGFA, VPF
Similar Products
−- Item 1 of 3
Human VEGF165 Protein, His Tag, low endotoxin (MALS verified) [orb257924]
Unconjugated
90%
21.1 kDa
1 mg, 50 μg 
Recombinant Human VEGF165 Protein [orb2995236]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 19.1 KDa. Observed: 18-24 KDa, reducing conditions
10 μg, 1 mg, 50 μg, 500 μgRecombinant Human VEGF165 Protein [orb2992805]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 20 KDa. Observed: 18-28 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Item 1 of 3
- Item 1 of 3
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
Protocol Information
Protein Handling and Storage Guide
Protein Handling Guide